Download Control / Prevention

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Brucellosis wikipedia , lookup

African trypanosomiasis wikipedia , lookup

Whooping cough wikipedia , lookup

Chickenpox wikipedia , lookup

Onchocerciasis wikipedia , lookup

Meningococcal disease wikipedia , lookup

Middle East respiratory syndrome wikipedia , lookup

2015–16 Zika virus epidemic wikipedia , lookup

Rinderpest wikipedia , lookup

Neglected tropical diseases wikipedia , lookup

Ebola virus disease wikipedia , lookup

Influenza A virus wikipedia , lookup

Norovirus wikipedia , lookup

Herpes simplex virus wikipedia , lookup

Neisseria meningitidis wikipedia , lookup

Hepatitis B wikipedia , lookup

West Nile fever wikipedia , lookup

Orthohantavirus wikipedia , lookup

Antiviral drug wikipedia , lookup

Marburg virus disease wikipedia , lookup

Pandemic wikipedia , lookup

Eradication of infectious diseases wikipedia , lookup

Herpes simplex research wikipedia , lookup

Henipavirus wikipedia , lookup

Transcript
Livestock Health, Management and Production › High Impact Diseases › Vector-borne Diseases ›
Bluetongue ›
Bluetongue
Author: Prof. N. J. Maclachlan
Adapted from:
1.
2.
3.
Verwoerd, D.W., Erasmus, B.J. 2004. Bluetongue, in Infectious diseases of livestock, edited by J.A.W.
Coetzer & R.C. Tustin. Oxford University Press, Cape Town, 2: 1201-1220.
Maclachlan, N.J.: Bluetongue: history, global epidemiology, and pathogenesis. Prev Vet Med., 102:107-111,
2011.
Maclachlan, N.J., Drew, C.P., Darpel, K., Wourwa, G.: The pathology and pathogenesis of bluetongue. J.
Comp. Pathol., 141: 1-16, 2009.
Licensed under a Creative Commons Attribution license.
CONTROL / PREVENTION
Strategies for the control of BT differ according to whether outbreaks of the disease occur in endemic
regions or in areas where the disease is not usually present. In the latter case the usual goal is
eradication, whereas in endemic areas attempts can only be made to limit the occurrence of the disease
and its economic impact.
In endemic areas, such as most of the African continent, a wide variety of domestic and wild ruminants
(including cattle, goats and various species of antelope) can act as sources of BT virus. Immunization of
cattle should therefore theoretically help to limit the incidence of BT, but the presence and ubiquitous
distribution of other reservoirs, both known and unknown, makes eradication of the disease impossible.
To date, BT virus has been isolated from seven species of Culicoides, of which at least four play an
important role in the transmission of BT in Africa and North America. Worldwide, a considerably greater
number of species have been implicated in transmission of BTV and it is likely that more species of
Culicoides, and even other insects, may be identified as biological vectors in future. Air-borne transport of
infected Culicoides midges over long distances cannot be prevented, but unless the insects can establish
themselves in the new environment epidemics which arise in this way are self-limiting unless the midges
resident in the new region can themselves then transmit the virus (as apparently occurred recently in
Europe).
Methods used to control Culicoides include the use of insecticides, larvicides and sterilization of males by
irradiation, as well as the subcutaneous administration of ivermectin to cattle in an attempt to break the
primary cycle before the infection spills over into sheep. Protecting sheep from exposure to Culicoides is
a more practical approach and can be achieved by avoiding low-lying wet pastures, stabling animals from
late afternoon till morning, shearing in early summer to allow some wool growth before the onset of the
BT season in late summer, and even the use of insect repellants.
1|Page
Livestock Health, Management and Production › High Impact Diseases › Vector-borne Diseases ›
Bluetongue ›
Prophylactic immunization of sheep remains the most effective and practical control measure against BT
in endemic regions. Vaccines comprised of attenuated virus strains are highly effective, especially in
epidemic situations where only one serotype of BT virus is involved. In endemic areas such as South
Africa, the situation is complicated by the existence of multiple serotypes. This necessitates the use of
polyvalent vaccines with attendant problems resulting from interference between virus strains, differences
in immunogenicity and growth rates between various strains, as well as differences in the response of
individual animals to the components of such vaccines. To overcome these problems, three pentavalent
vaccines have been developed in South Africa. They are administered to sheep at three-week intervals
and repeated annually. After two or three annual immunizations, most sheep are immune to all the
serotypes in the vaccine.
In addition to the inconvenience of repetitive inoculations of a multivalent vaccine there are some risks
involved in the use of live attenuated vaccines and some important precautions must be observed when
using them. Pregnant ewes should not be immunized during the first half of pregnancy, as brain defects
may result in the foetus.
The use of attenuated vaccine in ewes during the
first half of pregnancy may result in brain defects in the foetus
There are also indications of temporary infertility in both ewes and rams vaccinated for the first time,
necessitating immunization well before or after the mating season. However, this should not pose a
problem if sheep are vaccinated before they reach breeding age. More theoretical objections sometimes
raised against the use of live attenuated vaccines include the possibility of reassortment and
recombination between attenuated and virulent strains, resulting in reversion to virulence or even the
production of new serotypes, and the possibility that insects may spread the vaccine virus. Circulation of
live attenuated vaccine virus in animals and insects has been unambiguously proven in Europe recently,
as has reassortment of vaccine viruses with field virus.
Much progress has been made towards the development of safe, efficient, multivalent recombinant
vaccines which should contribute significantly to the control of bluetongue, hopefully in the near future.
2|Page
Livestock Health, Management and Production › High Impact Diseases › Vector-borne Diseases ›
Bluetongue ›
However, until that time, it is likely that live-attenuated and inactivated BT virus vaccines will be used in
areas where the virus is endemic and causes disease.
3|Page